4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4 Lenvatinib Mesylate Ma'ema'e Waena >98.0% (HPLC)
ʻO Ruifu Chemical Supply Lenvatinib Mesylate Intermediates Me ka Maʻemaʻe Kiʻekiʻe
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene)-2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Inoa Kimia | 4-Amino-3-Chlorophenol Hydrochloride |
Nā huaʻōlelo like | 2-Chloro-4-Hydroxyaniline Hydrochloride |
Helu CAS | 618-89-3 |
Helu CAT | RF-PI1969 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C6H6ClNO·HCl |
Kaumaha Molecular | 180.03 |
Lae hehee | 254.0~256.0℃(Dek.)(kumu) |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Pada Paʻa Palaka |
Maʻemaʻe / Kaʻina Hanana | >98.0% (HPLC) |
Maʻemaʻe / Kaʻina Hanana | 97.5~102.5% (Titration e AgNO3) |
Nalo ma ka maloo | <0.50% |
Koena ma ka Ignition | <0.30% |
Huina paumaele | <2.00% |
Infrared Spectrum | Kūlike i ka hoʻolālā |
Proton NMR Spectrum | Kūlike i ka hoʻolālā |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Waena o Lenvatinib Mesylate (CAS: 857890-39-2) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
ʻO 4-Amino-3-Chlorophenol Hydrochloride (CAS: 52671-64-4) he mea waena o Lenvatinib Mesylate (CAS: 857890-39-2).ʻO Lenvatinib (inoa kālepa ʻo Lenvima) he lāʻau anti-cancer no ka mālama ʻana i kekahi ʻano maʻi maʻi thyroid, a no nā maʻi maʻi ʻē aʻe kekahi.Hoʻohana ʻia ʻo Lenvatinib no ka mālama ʻana i ka maʻi maʻi thyroid ʻokoʻa i loaʻa a i ʻole metastatic kūloko, holomua, a ʻaʻole i pane i ka mālama ʻana me ka iodine radioactive (radioiodine).Hoʻohana ʻia ia e mālama i ka maʻi maʻi thyroid a me ka maʻi maʻi ʻaʻai.Hoʻohālikelike i nā mea hoʻopaneʻe kinase.ʻO Lenvatinib kahi mea hoʻopiʻi multi-target o VEGFR2 a me VEGFR3 me IC50 o 4 nM a me 5.2 nM, kēlā me kēia.